Document Classification

Section Type: RESULTS

Text: Treatment with ramipril resulted in reduced primary end point rates (11. 3 % vs. 14. 9 % in the placebo arm ; relative risk [RR] 0. 77, 95 % confidence interval [CI] 0. 62 to 0. 96 ; p = 0. 019), fewer strokes (3. 1 % vs. 4. 8 % ; RR 0. 64, 95 % CI 0. 43 to 0. 96 ; p = 0. 029) and fewer CV deaths (4. 2 % vs. 6. 9 % ; RR 0. 62, 95 % CI 0. 44 to 0. 88 ; p = 0. 0068).